Cargando…
Correlation between vascular endothelial growth factor pathway and immune microenvironment in head and neck squamous cell carcinoma
BACKGROUND: Immunotherapy is a crucial therapeutic approach in oncology. However, most patients with head and neck squamous cell carcinoma (HNSCC) do not derive benefit from immunotherapy. Vascular endothelial growth factor (VEGF)/VEGF Receptor 2 (VEGFR2) signaling pathway is one of the most importa...
Autores principales: | Zhu, Chao, Gu, Liqun, Liu, Zelong, Li, Jiang, Yao, Mianfeng, Fang, Changyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290614/ https://www.ncbi.nlm.nih.gov/pubmed/34284746 http://dx.doi.org/10.1186/s12885-021-08547-4 |
Ejemplares similares
-
Prognostic Value of an Immune-Related Gene Signature in Oral Squamous Cell Carcinoma
por: Zhu, Chao, et al.
Publicado: (2021) -
Potential for treatment benefit of STING agonists plus immune checkpoint inhibitors in oral squamous cell carcinoma
por: Zhu, Chao, et al.
Publicado: (2021) -
HNRNPA2B1, as a m(6)A Reader, Promotes Tumorigenesis and Metastasis of Oral Squamous Cell Carcinoma
por: Zhu, Feiya, et al.
Publicado: (2021) -
Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000) -
Plasma Vascular Endothelial Growth Factor Dysregulation in Defining Aggressiveness of Head and Neck Squamous Cell Carcinoma
por: Kulapaditharom, Boonchu, et al.
Publicado: (2012)